Portal Hypertension: From Pathophysiology to Clinical Practice
18th Nov 2005, 19:02 GMT
Complications of PHT are responsible for disabling morbidity and mortality in patients with cirrhosis. Decreasing portal pressure has therefore become a major target in treating these patients. Liver International
Portal Hypertension: From Pathophysiology to Clinical Practice related news:
- Adding a Research Component to Clinical Practice — Medscape Headlines
- Orthostatic hypotension following spinal cord injury: understanding clinical pathophysiology — Spinal Cord
- ORIGINAL ARTICLE: Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis — New England Journal of Medicine
- Highlights of the American College of Clinical Pharmacy 2005 Annual Meeting — Medscape Headlines
- Is the Era of Beta-Blockers for Hypertension Over? Is Race Important? Are the Brain and Hypertension Linked? — Medscape Headlines
- American College of Clinical Pharmacy 2005 Annual Meeting — Medscape Headlines
- High cholesterol tied to hypertension — RedOrbit News - Health
- EDITORIAL: Beta-Blockers to Prevent Esophageal Varices -- An Unfulfilled Promise — New England Journal of Medicine
- High cholesterol tied to hypertension (Reuters) — Yahoo! News: Health News
- The New Tuskegee: The Poor Exploited in Clinical Trials — blog.bioethics.net
Latest news from Medscape Headlines:
- New Treatment for Ischemic Stroke on the Horizon
- Adding Bevacizumab to First-Line Lung Cancer Therapy Shows Potential
- Type 1 and 2 T Helper Cell-mediated Colitis
- Radiation Therapy for Chronic Vesicular Hand Dermatitis
- November 14, 2006: In the News
- Alcoholic Liver Disease-Pathophysiological Aspects and Risk Factors
- Overweight in Celiac Disease: Prevalence, Clinical Characteristics, and Effect of a Gluten-Free Diet
- Bleeding-Edge Benefits
- End-Stage Renal Disease and Drug-Eluting Stents: One Small Step Forward?
- November 13, 2006: In the News